Plasma pancreatic polypeptide response to secretin

European Journal of Endocrinology

Volumn 141, Issue 1, 1999, Pages 47-49

  Peracchi, Maddalena ^b   Tagliabue, Rosalia ^b   Quatrini, Maurizio ^b   Reschini, Eugenio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; PANCREAS POLYPEPTIDE; SECRETIN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GASTRIN BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPERGASTRINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; ZOLLINGER ELLISON SYNDROME;

ADULT; AGED; DUODENAL ULCER; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HUMANS; KINETICS; MALE; MIDDLE AGED; PANCREATIC POLYPEPTIDE; SECRETIN; ZOLLINGER-ELLISON SYNDROME;

EID: 0032788527     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410047     Document Type: Article

References (15)

1. Meko JB & Norton JA. Management of patients with Zollinger-Ellison syndrome. Annual Review of Medicine 1995 46 395-411.
2. Rigaud D, Accary JP, Mignon M & Bonfilis S. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger Ellison syndrome. Digestive Diseases and Science 1984 29 696-702.
3. Strodel WE, Vinik AI, Lloyd RV, Glaser B, Eckhauser FE, Fiddian-Creen RG et al. Pancreatic polypeptide producing tumors. Archives of Surgery 1984 119 508-514.
4. Adrian TE, Besterman HS, Cooke TJC, Faber RG, Bloom SR, Barnes AJ et al. Mechanism of pancreatic polypeptide release in man. Lancet 1977 1 161-163.
5. Schwarte TW & Rehfeld JJ. Mechanism of pancreatic polypeptide release. Lancet 1977 1 697-698.
6. Glaser B, Vinik AI, Sive AA & Floyd JC. Plasma human pancreatic polypeptide responses to administered secretin: effects of surgical vagotomy, cholinergic blockade, and chronic pancreatitis. Journal of Clinical Endocrinology and Metabolism 1980 50 1094-1099.
7. Diem P, Redman JB, Abid M, Moran A, Sutherland DER, Halter JB et al. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. Journal of Clinical Investigation 1990 86 2008-201 3.
8. Rasmussen MH, Carstensen H, List S, Schwartz TW & Hilsted J. Impaired pancreatic polypeptide response to meal in type 1 diabetic patients: vagal neuropathy or islet cell disfunction? Acta Endocrinologica 1993 128 221-224.
9. Corbetta S, Pizzocaro A, Peracchi M, Beck-Peccoz P, Faglia G & Spada A. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types. Clinical Endocrinology 1997 47 507-512.
10. Friesen SR, Kimmel JR & Tomita T. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies. American Journal of Surgery 1980 139 61-71.
11. Öberg K, Grimelius L, Lundqvist G & Lörelius LE. Udpate on pancreatic polypeptide as a specific marker for endocrine tumours of the pancreas and gut. Acta Medica Scandinavica 1981 210 145-152.
12. Lamers CBHW & Diemel M. Basal and post atropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I. Journal of Clinical Endocrinology and Metabolism 1982 55 774-778.
13. Schwartz TW. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983 85 1411-1425.
14. Adrian TE, Uttenthal LO, Williams SJ & Bloom SR. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. New England Journal of Medicine 1986 315 287-291.
15. Skogseid B, Öberg K, Benson L, Lindgren PG, Lörelius LE, Lundqvist G et al. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. Journal of Clinical Endocrinology and Metabolism 1987 64 1233-1240.